ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Missouri » Neurology

Top Neurology Prescribers in Missouri

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
MIGNON MAKOS MD

Neurology

7,878

$1.24M

569
380 are 65+

2%
patients receiving schedule two controlled substances

Avg: 2%

6%
patients receiving schedule three controlled substances

Avg: 4%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

28%
prescriptions for brand name drugs

Avg: 24%

$157
Average prescription price

Avg: $221

JENIFER ZHAI MD

Neurology

7,806

$2.27M

747
451 are 65+

2%
patients receiving schedule two controlled substances

Avg: 2%

7%
patients receiving schedule three controlled substances

Avg: 4%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

24%
prescriptions for brand name drugs

Avg: 24%

$291
Average prescription price

Avg: $221

DIANE CORNELISON DO

Neurology

7,266

$728K

716
321 are 65+

37%
patients receiving schedule two controlled substances

Avg: 2%

40%
patients receiving schedule three controlled substances

Avg: 4%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

18%
prescriptions for brand name drugs

Avg: 24%

$100
Average prescription price

Avg: $221

SHAVETA MANCHANDA MD

Neurology

7,100

$1.38M

697
460 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

4%
patients receiving schedule three controlled substances

Avg: 4%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

24%
prescriptions for brand name drugs

Avg: 24%

$195
Average prescription price

Avg: $221

SUDHIR BATCHU MD

Neurology

7,001

$1.68M

459
209 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

4%
patients receiving schedule three controlled substances

Avg: 4%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

25%
prescriptions for brand name drugs

Avg: 24%

$240
Average prescription price

Avg: $221

ABDUL CHAUDHARI M.D.

Neurology

6,725

$687K

299
149 are 65+

28%
patients receiving schedule two controlled substances

Avg: 2%

38%
patients receiving schedule three controlled substances

Avg: 4%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

22%
prescriptions for brand name drugs

Avg: 24%

$102
Average prescription price

Avg: $221

AHMED ROBBIE MD

Neurology

6,151

$730K

623
331 are 65+

5%
patients receiving schedule two controlled substances

Avg: 2%

13%
patients receiving schedule three controlled substances

Avg: 4%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

20%
prescriptions for brand name drugs

Avg: 24%

$119
Average prescription price

Avg: $221

LEE TEMPEL MD

Neurology

6,062

$1.07M

398
325 are 65+

4%
patients receiving schedule two controlled substances

Avg: 2%

7%
patients receiving schedule three controlled substances

Avg: 4%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

30%
prescriptions for brand name drugs

Avg: 24%

$176
Average prescription price

Avg: $221

KENNETH SHARLIN MD

Neurology

5,673

$921K

329
69 are 65+

22%
patients receiving schedule two controlled substances

Avg: 2%

10%
patients receiving schedule three controlled substances

Avg: 4%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

24%
prescriptions for brand name drugs

Avg: 24%

$162
Average prescription price

Avg: $221

WILLIAM ROSENFELD M.D.

Neurology

5,189

$1.39M

224
43 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 4%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

41%
prescriptions for brand name drugs

Avg: 24%

$268
Average prescription price

Avg: $221

RAVINDER ARORA M.D.

Neurology

4,929

$656K

452
217 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

5%
patients receiving schedule three controlled substances

Avg: 4%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

32%
prescriptions for brand name drugs

Avg: 24%

$133
Average prescription price

Avg: $221

FREDERICK TURPIN D.O.

Neurology

4,732

$986K

460
294 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

4%
patients receiving schedule three controlled substances

Avg: 4%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

23%
prescriptions for brand name drugs

Avg: 24%

$208
Average prescription price

Avg: $221

MIN PAN M.D.

Neurology

4,504

$1.03M

440
331 are 65+

6%
patients receiving schedule two controlled substances

Avg: 2%

5%
patients receiving schedule three controlled substances

Avg: 4%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

25%
prescriptions for brand name drugs

Avg: 24%

$229
Average prescription price

Avg: $221

MAX BENZAQUEN MD

Neurology

4,435

$650K

533
433 are 65+

4%
patients receiving schedule two controlled substances

Avg: 2%

3%
patients receiving schedule three controlled substances

Avg: 4%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

28%
prescriptions for brand name drugs

Avg: 24%

$147
Average prescription price

Avg: $221

JAMIE HAAS M.D.

Neurology

4,214

$940K

443
222 are 65+

5%
patients receiving schedule two controlled substances

Avg: 2%

3%
patients receiving schedule three controlled substances

Avg: 4%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

18%
prescriptions for brand name drugs

Avg: 24%

$223
Average prescription price

Avg: $221

BARRY SINGER

Neurology

4,139

$3.85M

324
184 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

5%
patients receiving schedule three controlled substances

Avg: 4%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

42%
prescriptions for brand name drugs

Avg: 24%

$930
Average prescription price

Avg: $221

ROBERT BURGER MD

Neurology

4,098

$1.36M

222
55 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

7%
patients receiving schedule three controlled substances

Avg: 4%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

20%
prescriptions for brand name drugs

Avg: 24%

$332
Average prescription price

Avg: $221

STEVEN MELLIES DO

Neurology

3,837

$592K

320
150 are 65+

4%
patients receiving schedule two controlled substances

Avg: 2%

8%
patients receiving schedule three controlled substances

Avg: 4%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

23%
prescriptions for brand name drugs

Avg: 24%

$154
Average prescription price

Avg: $221

RANDALL STAHLY D.O.

Neurology

3,829

$854K

414
291 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

5%
patients receiving schedule three controlled substances

Avg: 4%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

32%
prescriptions for brand name drugs

Avg: 24%

$223
Average prescription price

Avg: $221

CHRISTOPHER ANDREW MD

Neurology

3,770

$780K

407
215 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

7%
patients receiving schedule three controlled substances

Avg: 4%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

22%
prescriptions for brand name drugs

Avg: 24%

$207
Average prescription price

Avg: $221

ROGER OGHLAKIAN MD

Neurology

3,750

$423K

326
95 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 4%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

21%
prescriptions for brand name drugs

Avg: 24%

$113
Average prescription price

Avg: $221

LARRY HOLLENBECK MD

Neurology

3,740

$1.28M

333
215 are 65+

5%
patients receiving schedule two controlled substances

Avg: 2%

5%
patients receiving schedule three controlled substances

Avg: 4%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

25%
prescriptions for brand name drugs

Avg: 24%

$343
Average prescription price

Avg: $221

ABUL FAZAL ALI M.D.

Neurology

3,697

$371K

286
115 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

12%
patients receiving schedule three controlled substances

Avg: 4%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

23%
prescriptions for brand name drugs

Avg: 24%

$100
Average prescription price

Avg: $221

SREENADHA DAVULURI MD

Neurology

3,630

$1.39M

427
254 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 4%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

34%
prescriptions for brand name drugs

Avg: 24%

$382
Average prescription price

Avg: $221

DONALD HOPEWELL MD

Neurology

3,629

$371K

244
109 are 65+

61%
patients receiving schedule two controlled substances

Avg: 2%

38%
patients receiving schedule three controlled substances

Avg: 4%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

14%
prescriptions for brand name drugs

Avg: 24%

$102
Average prescription price

Avg: $221

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank